Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells
Author:
Affiliation:
1. Department of Pediatric Surgery, People's Hospital of Zhengzhou University, Zhengzhou, China
2. Department of Ophthalmology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/07357907.2016.1212205
Reference13 articles.
1. Prognostic factors in osteosarcoma: a critical review.
2. Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis
3. TNF-α Induces Two Distinct Caspase-8 Activation Pathways
4. Survivin as a Prognostic Factor for Osteosarcoma Patients
5. Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy;Journal of Medicinal Chemistry;2023-12-11
2. Adsorption property of fluoride in water by metal organic framework: Optimization of the process by response surface methodology technique;Surfaces and Interfaces;2022-02
3. Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment;Journal of Cancer Research and Clinical Oncology;2021-12-03
4. Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy;Journal of Clinical Medicine;2021-02-23
5. Bone Tumors: Types and Treatments;Hormone Therapy and Replacement in Cancer and Aging-related Diseases;2020-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3